REFERENCES
- Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer. 1998;83:2638–2648.
- Grebe SK, Hay ID. Prognostic factors and management in thyroid cancer–consensus or controversy? West J Med. 1996;165:156–157.
- Qubain SW, Nakano S, Baba M, et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 2002;131:249–256.
- American Thyroid Association Surgery Working Group; American Association of Endocrine Surgeons; American Academy of Otolaryngology-Head and Neck Surgery; American Head and Neck Society, Carty SE, Cooper DS, Doherty GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19:1153–1158.
- Podnos YD, Smith D, Wagman LD, et al. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg. 2005;71:731–734.
- Giordano D, Valcavi R, Thompson GB, et al. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid. 2012;22:911–917.
- Roberts H, Donati-Bourne JF, Wilson V, et al. The Use of Live Fluorescence Staining Techniques in Surgery: A Review. J Invest Surg. 2013;26:283–293.
- Larrad Jimenez A, de Quadros Borrajo P, Martin Duce A. Evaluation of the sentinel lymph node in T1-T2 papillary thyroid cancer: a preliminary study. Cir Esp. 2012;90:440–445.
- Pelizzo MR, Rubello D, Boschin IM, et al. Contribution of SLN investigation with 99mTc-nanocolloid in clinical staging of thyroid cancer: technical feasibility. Eur J Nucl Med Mol Imaging. 2007;34:934–938.
- Garcia-Burillo A, Roca Bielsa I, Gonzalez O, et al. SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement. Eur J Nucl Med Mol Imaging. 2013;40:1645–1655.
- Sagara Y, Ohi Y, Matsukata A, et al. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer. Breast Cancer. 2013;20:181–186.
- Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer. 2008;122:2562–2567.
- de Danschutter SJ, Schreinemakers JM, Smit LH, et al. Thyroid surgery and the usefulness of intraoperative neuromonitoring, a single center study. J Invest Surg. 2014 Nov 10. [Epub ahead of print]
- Wanebo HJ, LeGolvan M, Paty PB, et al. Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis. 2012;29:821–839.
- Chaudhry A, Williams S, Cook J, et al. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making. Eur J Surg Oncol. 2014 Feb;40(2):150–157.
- Kumagai K, Yamamoto N, Miyashiro I, et al. Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer. 2014;17:273–280.
- Vilardell F, Novell A, Martin J, et al. Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA. Virchows Arch. 2012;460:569–575.
- Heilmann T, Mathiak M, Hofmann J, et al. Intra-operative use of one-step nucleic acid amplification (OSNA) for detection of the tumor load of sentinel lymph nodes in breast cancer patients. J Cancer Res Clin Oncol. 2013;139: 1649–1655.